Lumacaftor and ivacaftor is applied to treat specified kinds of cystic fibrosis (an inborn ailment that triggers issues with respiration, digestion, and copy) in Older people and children 1 12 months of age and more mature. Lumacaftor is in a category of medications identified as cystic fibrosis transmembrane conductance regulator https://ericq530ejn2.blogvivi.com/profile